In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

AlphaRx > Message
Generic_profile

Re: NEWS - AlphaRx and Proprius Pharmaceuticals Achieve Enrollment Objective in Phase II Trial of Indaflex(TM) for Osteoarthritis of the Knee

Posted by: helloalpha on December 12, 2006 01:21AM

In response to: Re: NEWS - AlphaRx and Prop... by Tutty

well, 6 weeks treatment will take us to end of january, so we should see results by early march., just 3 more months to go.

Post a Reply

Please login to reply to this message.

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote